These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10367825)

  • 1. The need for global action against multidrug-resistant tuberculosis.
    Heymann SJ; Brewer TF; Wilson ME; Fineberg HV
    JAMA; 1999 Jun; 281(22):2138-40. PubMed ID: 10367825
    [No Abstract]   [Full Text] [Related]  

  • 2. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 3. Infection Prevention And Control In TB Programs.
    Trusov A; Ismoilova J; Tonkel T; Aleksandrin A
    Health Aff (Millwood); 2016 Mar; 35(3):556. PubMed ID: 26953318
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress towards achieving global tuberculosis control: so near, yet so far.
    Zumla A; Davies PD
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):285-6. PubMed ID: 27046703
    [No Abstract]   [Full Text] [Related]  

  • 6. Stronger health systems to beat TB.
    Sampaio J
    Bull World Health Organ; 2007 May; 85(5):333. PubMed ID: 17639215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards TB reduction targets is faltering, report finds.
    Cousins S
    BMJ; 2017 Oct; 359():j4758. PubMed ID: 29030533
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effective control of drug-resistant TB: listening to other voices.
    Portero JL; Rubio M
    PLoS Med; 2006 Dec; 3(12):e542. PubMed ID: 17194207
    [No Abstract]   [Full Text] [Related]  

  • 9. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fight to end tuberculosis: a global challenge in strong partnership.
    Martini M; Barberis I; Gazzaniga V; Icardi G
    J Prev Med Hyg; 2020 Mar; 61(1 Suppl 1):E1-E2. PubMed ID: 32529096
    [No Abstract]   [Full Text] [Related]  

  • 12. Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium.
    Blasi F; Dara M; van der Werf MJ; Migliori GB
    Eur Respir J; 2013 Mar; 41(3):491-4. PubMed ID: 23456928
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance.
    Kaye K; Frieden TR
    Epidemiol Rev; 1996; 18(1):52-63. PubMed ID: 8877330
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps.
    O'Brien RJ; Nunn PP
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1055-8. PubMed ID: 11316634
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-border patients with tuberculosis.
    Reynolds PN; Turnidge JD; Gottlieb T; Moore MJ; ; ; ;
    Med J Aust; 2011 Nov; 195(9):523-4. PubMed ID: 22060085
    [No Abstract]   [Full Text] [Related]  

  • 16. How to ensure the continued resurgence of tuberculosis.
    Reichman LB
    Lancet; 1996 Jan; 347(8995):175-7. PubMed ID: 8544556
    [No Abstract]   [Full Text] [Related]  

  • 17. Tackling the spread of drug-resistant tuberculosis in Europe.
    Abubakar I; Dara M; Manissero D; Zumla A
    Lancet; 2012 Jan; 379(9813):e21-3. PubMed ID: 21924489
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable?
    Loddenkemper R; Sotgiu G; Mitnick CD
    Eur Respir J; 2012 Jul; 40(1):9-11. PubMed ID: 22753833
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond directly observed therapy for tuberculosis.
    Nolan CM
    Chest; 1997 May; 111(5):1151-3. PubMed ID: 9149558
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis control poses global challenges.
    Traynor K
    Am J Health Syst Pharm; 2007 Aug; 64(16):1672-4. PubMed ID: 17687052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.